» Articles » PMID: 27688656

Gastrointestinal Disorders Associated with Migraine: A Comprehensive Review

Overview
Specialty Gastroenterology
Date 2016 Oct 1
PMID 27688656
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is a recurrent and commonly disabling primary headache disorder that affects over 17% of women and 5%-8% of men. Migraine susceptibility is multifactorial with genetic, hormonal and environmental factors all playing an important role. The physiopathology of migraine is complex and still not fully understood. Many different neuropeptides, neurotransmitters and brain pathways have been implicated. In connection with the myriad mechanisms and pathways implicated in migraine, a variety of multisystemic comorbidities (e.g., cardiovascular, psychiatric and other neurological conditions) have been found to be closely associated with migraine. Recent reports demonstrate an increased frequency of gastrointestinal (GI) disorders in patients with migraine compared with the general population. Helicobacter pylori infection, irritable bowel syndrome, gastroparesis, hepatobiliary disorders, celiac disease and alterations in the microbiota have been linked to the occurrence of migraine. Several mechanisms involving the gut-brain axis, such as a chronic inflammatory response with inflammatory and vasoactive mediators passing to the circulatory system, intestinal microbiota modulation of the enteric immunological milieu and dysfunction of the autonomic and enteric nervous system, have been postulated to explain these associations. However, the precise mechanisms and pathways related to the gut-brain axis in migraine need to be fully elucidated. In this review, we survey the available literature linking migraine with GI disorders. We discuss the possible physiopathological mechanisms, and clinical implications as well as several future areas of interest for research.

Citing Articles

The Gut Microbiome and Migraine: Updates in Understanding.

Zhang N, Tran S, Moskatel L Curr Neurol Neurosci Rep. 2025; 25(1):20.

PMID: 39985639 DOI: 10.1007/s11910-025-01408-8.


Shared genetic risk and causal associations between Post-traumatic stress disorder and migraine with antithrombotic agents and other medications.

Bainomugisa C, Bruenig D, Sutherland H, Griffiths L, Nyholt D, Mehta D Neurobiol Stress. 2025; 34:100703.

PMID: 39898008 PMC: 11786899. DOI: 10.1016/j.ynstr.2024.100703.


The Interplay Between Gut Microbiota, Adipose Tissue, and Migraine: A Narrative Review.

Biagioli V, Mela F, Ferraro P, Villano G, Orsini A, Diana M Nutrients. 2025; 17(2).

PMID: 39861467 PMC: 11768392. DOI: 10.3390/nu17020337.


Sexual Dimorphism in Migraine. Focus on Mitochondria.

Fila M, Przyslo L, Derwich M, Pawlowska E, Blasiak J Curr Pain Headache Rep. 2025; 29(1):11.

PMID: 39760955 DOI: 10.1007/s11916-024-01317-4.


Effects of probiotic and vitamin D co-supplementation on clinical symptoms, mental health, and inflammation in adult patients with migraine headache: a randomized, triple-blinded, placebo-controlled trial.

Tirani S, Khorvash F, Saneei P, Moradmand Z, Askari G BMC Med. 2024; 22(1):457.

PMID: 39394141 PMC: 11470646. DOI: 10.1186/s12916-024-03684-6.


References
1.
Nilsson S, Edvinsson L, Malmberg B, Johansson B, Linde M . A relationship between migraine and biliary tract disorders: findings in two Swedish samples of elderly twins. Acta Neurol Scand. 2010; 122(4):286-94. DOI: 10.1111/j.1600-0404.2009.01310.x. View

2.
Ilgaz Aydinlar E, Yalinay Dikmen P, Tiftikci A, Saruc M, Aksu M, Gunsoy H . IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2012; 53(3):514-25. DOI: 10.1111/j.1526-4610.2012.02296.x. View

3.
Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B . Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013; 144(7):1394-401, 1401.e1-4. PMC: 3839572. DOI: 10.1053/j.gastro.2013.02.043. View

4.
Victor T, Hu X, Campbell J, Buse D, Lipton R . Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010; 30(9):1065-72. DOI: 10.1177/0333102409355601. View

5.
Schlesinger I, Hering R . Antigliadin antibodies in migraine patients. Cephalalgia. 1997; 17(6):712. DOI: 10.1177/033310249701700616. View